NASDAQ:PTE PolarityTE (PTE) Stock Price, News & Analysis → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free PTE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.20▼$0.5752-Week Range N/AVolume8.50 million shsAverage Volume249,591 shsMarket Capitalization$1.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get PolarityTE alerts: Email Address Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. About PolarityTE Stock (NASDAQ:PTE)PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.Read More Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. PTE Stock News HeadlinesApril 19, 2024 | morningstar.comRegenetp Inc RGTPQJanuary 6, 2024 | finance.yahoo.comRegenETP, Inc. (NJT.SG)April 23, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...June 9, 2023 | benzinga.comPolarityTE Stock (NASDAQ:PTE), DividendsJune 7, 2023 | benzinga.comPolarityTE shares are trading lower after the company filed voluntary petitions for relief under Chapter 11.May 15, 2023 | uk.finance.yahoo.comPolarityTE, Inc. (PTE) stock price, news, quote & history – Yahoo FinanceApril 25, 2023 | finance.yahoo.comPolarityTE, Inc. (PTE) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowMarch 29, 2023 | finance.yahoo.comPolarityTE Full Year 2022 Earnings: EPS Misses ExpectationsApril 23, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...March 23, 2023 | finance.yahoo.comWhen Can We Expect A Profit From PolarityTE, Inc. (NASDAQ:PTE)?December 30, 2022 | msn.comNorthland Capital Markets Maintains Outperform Rating for PolarityTE: Here's What You Need To KnowDecember 27, 2022 | finance.yahoo.comPolarityTE Announces Entry Into a Letter of Intent For Acquisition of the CompanyDecember 12, 2022 | finance.yahoo.comPolarityTE, Inc. (PTE) Stock Historical Prices & Data - Yahoo FinanceNovember 10, 2022 | finance.yahoo.comPolarityTE Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 9, 2022 | finance.yahoo.comPolarityTE Shares Jump After Non-Binding Buyout Offer Of $1.25/ShareNovember 9, 2022 | finance.yahoo.comPolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the CompanyOctober 17, 2022 | msn.comUS Futures Higher as Bank of America Reports Better-Than-Expected Earnings - msnNOWOctober 14, 2022 | nasdaq.comPolarityTE, Inc. (PTE) Upgraded to Strong Buy: Here's What You Should Know - NasdaqOctober 13, 2022 | finance.yahoo.comPolarityTE, Inc. (PTE) Upgraded to Strong Buy: Here's What You Should KnowSeptember 24, 2022 | reuters.comPTE.OQ - Polarityte Inc | Stock Price & Latest News | ReutersSeptember 19, 2022 | seekingalpha.comASP Isotopes Starts $30 Million U.S. IPO Process (Pending:ASPI) - Seeking AlphaSeptember 14, 2022 | benzinga.comPolarityTE (NASDAQ:PTE) – PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conf - BenzingaSeptember 13, 2022 | streetinsider.comPolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022 - StreetInsider.comSeptember 13, 2022 | finance.yahoo.comPolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022September 8, 2022 | prnewswire.comPolarityTE Announces Resignation of Jeff Dyer from its Board of Directors - PR NewswireSeptember 8, 2022 | finance.yahoo.comPolarityTE Announces Resignation of Jeff Dyer from its Board of DirectorsSeptember 7, 2022 | msn.comPolarityTE's Return On Capital Employed OverviewSee More Headlines Receive PTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PolarityTE and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/10/2021Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:PTE CUSIPN/A CIK1076682 Webwww.polarityte.com Phone(800) 560-3983Fax302-636-5454Employees42Year Founded1986Profitability EPS (Most Recent Fiscal Year)($3.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,830,000.00 Net MarginsN/A Pretax Margin-11,376.71% Return on Equity-106.08% Return on Assets-76.91% Debt Debt-to-Equity RatioN/A Current Ratio4.11 Quick Ratio4.11 Sales & Book Value Annual Sales$810,000.00 Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$2.30 per share Price / BookN/AMiscellaneous Outstanding Shares7,380,000Free Float6,978,000Market Cap$1.78 million OptionableOptionable Beta1.15 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Richard Hague (Age 63)Pres & CEO Comp: $479.81kMr. Jacob Alexander Patterson (Age 44)Chief Financial Officer Comp: $262.85kMr. Nikolai SopkoChief Scientific Officer and VP of R&DMr. Rich HaerleVP of Investor Relations & StrategyMr. Mark E. Lehman J.D.Chief Legal OfficerAngela ZieglerVP of Marketing & PRMr. Alain AdamVP of SalesDr. Jon Anthony Joseph Burrows B.Sc. (Age 60)M.Sc., Ph.D., Sr. VP of Corp. Devel. & Pres of Contract Services Mr. Ryan Mathis M.D.Chief Medical OfficerMr. Kolby Day Esq.Sr. VP of Manufacturing OperationsMore ExecutivesKey CompetitorsWindtree TherapeuticsNASDAQ:WINTSQZ BiotechnologiesNYSE:SQZGamida CellNASDAQ:GMDAGamida CellNASDAQ:GMDAQTC BiopharmNASDAQ:TCBPView All Competitors PTE Stock Analysis - Frequently Asked Questions How were PolarityTE's earnings last quarter? PolarityTE, Inc. (NASDAQ:PTE) announced its earnings results on Wednesday, November, 10th. The company reported ($2.25) EPS for the quarter, topping the consensus estimate of ($3.00) by $0.75. The company had revenue of $1.12 million for the quarter, compared to analyst estimates of $0.97 million. During the same quarter last year, the business posted ($4.50) earnings per share. When did PolarityTE's stock split? PolarityTE's stock reverse split before market open on Tuesday, May 17th 2022. The 1-25 reverse split was announced on Tuesday, May 17th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 17th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. What other stocks do shareholders of PolarityTE own? Based on aggregate information from My MarketBeat watchlists, some companies that other PolarityTE investors own include Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), Pennsylvania Real Estate Investment Trust (PEI), CNBX Pharmaceuticals (CNBX), Novan (NOVN), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), KushCo (KSHB) and Aeterna Zentaris (AEZS). This page (NASDAQ:PTE) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PolarityTE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
